Osteopore International Pte Ltd (Osteopore International) is a medical devices company. It designs, develops and markets surgical implants based on bioresorbable polycaprolactone (PCL), which is a malleable and slow-degrading polymer. The company’s product portfolio includes osteoplug, a bioresorbable implant used for filling up trephination burr holes in neurosurgery; and osteomesh, a bioresorbable implant employed in craniofacial surgery to fix various types of fractures such as orbital floor fracture and other surgical defects. Osteopore International manufactures 3-dimensional (3D) scaffolds using its proprietary technologies that empower bone regeneration tissue. The company’s products find application in neurosurgical, orthopedic, and maxillofacial surgery. It distributes its products to Korea, Asia, and the US. Osteopore International is headquartered in Singapore City, Singapore.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Osteopore International Pte Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Osteopore International Pte Ltd Company Overview
- Osteopore International Pte Ltd Company Snapshot
- Osteopore International Pte Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Osteopore International Pte Ltd - Pipeline Analysis Overview
- Osteopore International Pte Ltd - Key Facts
- Osteopore International Pte Ltd - Major Products and Services
- Osteopore International Pte Ltd Pipeline Products by Development Stage
- Osteopore International Pte Ltd Ongoing Clinical Trials by Trial Status
- Osteopore International Pte Ltd Pipeline Products Overview
- 3D Printed Cage - Leg Amputation
- 3D Printed Cage - Leg Amputation Product Overview
- 3D-Printed Bone Implant
- 3D-Printed Bone Implant Product Overview
- Aesthetic Genioplasty (Chin) Device
- Aesthetic Genioplasty (Chin) Device Product Overview
- Aesthetic Nipple Reconstruction Device
- Aesthetic Nipple Reconstruction Device Product Overview
- aXOpore OTO Wedge
- aXOpore OTO Wedge Product Overview
- Breast Reconstruction Device
- Breast Reconstruction Device Product Overview
- Dental Guide Tissue Regeneration Implant
- Dental Guide Tissue Regeneration Implant Product Overview
- Mandible Reconstruction Device
- Mandible Reconstruction Device Product Overview
- Next Generation Jaw Implant
- Next Generation Jaw Implant Product Overview
- Oral Maxillofacial Cleft Palate Reconstruction Implant
- Oral Maxillofacial Cleft Palate Reconstruction Implant Product Overview
- Orthopaedic Clavicle Reconstruction Implant
- Orthopaedic Clavicle Reconstruction Implant Product Overview
- Orthopaedic Tendon Repair Implant
- Orthopaedic Tendon Repair Implant Product Overview
- Orthopaedic Tibia Reconstruction Implant
- Orthopaedic Tibia Reconstruction Implant Product Overview
- PCL-TCP 3D-Printed Bone Scaffold
- PCL-TCP 3D-Printed Bone Scaffold Product Overview
- PCL-TCP 3D-Printed Bone Scaffold Clinical Trial
- Radial Bone Reconstruction Implant
- Radial Bone Reconstruction Implant Product Overview
- Osteopore International Pte Ltd - Key Competitors
- Osteopore International Pte Ltd - Key Employees
- Osteopore International Pte Ltd - Locations And Subsidiaries
- Head Office
- Recent Developments
- Osteopore International Pte Ltd, Recent Developments
- Jan 14, 2025: Osteopore Implants Added to Singapore’s Ministry of Health’s Subsidy List
- Aug 22, 2024: Osteopore and the University of Chile Successfully Complete Pre-clinical Bone Implant Studies
- Apr 23, 2024: Osteopore : First-In-Human Clinical Trials Begin In Singapore
- May 16, 2023: Largest South African medical insurer provides cover for Osteomesh
- Mar 27, 2023: Osteopore product approved for additional applications in Taiwan
- Feb 14, 2023: Osteopore enters orthopaedic market with 2nd generation product registered in Great Britain
- Dec 08, 2022: Increased presence and commercial opportunities across South East Asia
- Sep 28, 2022: Osteopore to Develop Implants That Accelerate Bone Regeneration
- May 10, 2022: Osteopore enters oral & maxillofacial market in Australia & New Zealand
- Apr 14, 2022: Osteopore expands further into Europe with initial sales to Spain
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Osteopore International Pte Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Osteopore International Pte Ltd Pipeline Products by Equipment Type
- Osteopore International Pte Ltd Pipeline Products by Indication
- Osteopore International Pte Ltd Ongoing Clinical Trials by Trial Status
- Osteopore International Pte Ltd, Key Facts
- Osteopore International Pte Ltd, Major Products and Services
- Osteopore International Pte Ltd Number of Pipeline Products by Development Stage
- Osteopore International Pte Ltd Pipeline Products Summary by Development Stage
- Osteopore International Pte Ltd Ongoing Clinical Trials by Trial Status
- Osteopore International Pte Ltd Ongoing Clinical Trials Summary
- 3D Printed Cage - Leg Amputation - Product Status
- 3D Printed Cage - Leg Amputation - Product Description
- 3D-Printed Bone Implant - Product Status
- 3D-Printed Bone Implant - Product Description
- Aesthetic Genioplasty (Chin) Device - Product Status
- Aesthetic Genioplasty (Chin) Device - Product Description
- Aesthetic Nipple Reconstruction Device - Product Status
- Aesthetic Nipple Reconstruction Device - Product Description
- aXOpore OTO Wedge - Product Status
- aXOpore OTO Wedge - Product Description
- Breast Reconstruction Device - Product Status
- Breast Reconstruction Device - Product Description
- Dental Guide Tissue Regeneration Implant - Product Status
- Dental Guide Tissue Regeneration Implant - Product Description
- Mandible Reconstruction Device - Product Status
- Mandible Reconstruction Device - Product Description
- Next Generation Jaw Implant - Product Status
- Next Generation Jaw Implant - Product Description
- Oral Maxillofacial Cleft Palate Reconstruction Implant - Product Status
- Oral Maxillofacial Cleft Palate Reconstruction Implant - Product Description
- Orthopaedic Clavicle Reconstruction Implant - Product Status
- Orthopaedic Clavicle Reconstruction Implant - Product Description
- Orthopaedic Tendon Repair Implant - Product Status
- Orthopaedic Tendon Repair Implant - Product Description
- Orthopaedic Tibia Reconstruction Implant - Product Status
- Orthopaedic Tibia Reconstruction Implant - Product Description
- PCL-TCP 3D-Printed Bone Scaffold - Product Status
- PCL-TCP 3D-Printed Bone Scaffold - Product Description
- PCL-TCP 3D-Printed Bone Scaffold - Assessment of 3D-Printed Patient Specific Scaffolds for Nasoalveolar Augmentation in Patients with Cleft Lip-Related Paranasal Maxillary Deformities
- PCL-TCP 3D-Printed Bone Scaffold - The BONE-RECON Trial: A Single-arm Feasibility Trial Evaluating the Mpcl-tcp Scaffold System with Corticoperiosteal Tissue Transfer for Reconstruction of Critical Sized Lower Limb Bone Defects
- Radial Bone Reconstruction Implant - Product Status
- Radial Bone Reconstruction Implant - Product Description
- Osteopore International Pte Ltd, Key Employees
- Glossary
- Osteopore International Pte Ltd Pipeline Products by Equipment Type
- Osteopore International Pte Ltd Pipeline Products by Development Stage
- Osteopore International Pte Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- JMS Singapore Pte Ltd
- Merlin MD Pte. Ltd.
- Forefront Medical Technology Pte Ltd
